re: morphosys news There are real synergies between the platforms. Phylogica's peptides can hit intracellular targets which Morphosys antibodies cannot. Also Phylogica can conjugate their peptides to their antibodies to pull them across cell membrane.
- Forums
- ASX - By Stock
- PYC
- re: morphosys news
PYC
pyc therapeutics limited
Add to My Watchlist
1.73%
!
$1.47

re: morphosys news, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.47 |
Change
0.025(1.73%) |
Mkt cap ! $857.3M |
Open | High | Low | Value | Volume |
$1.44 | $1.47 | $1.43 | $52.55K | 36.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 12772 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 22683 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 12772 | 1.450 |
2 | 11611 | 1.435 |
3 | 45691 | 1.430 |
6 | 10251 | 1.420 |
3 | 12966 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.470 | 22683 | 1 |
1.475 | 20548 | 2 |
1.480 | 1961 | 2 |
1.485 | 756 | 1 |
1.490 | 36414 | 3 |
Last trade - 10.43am 10/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |